Verbio (VBK) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
12 Nov, 2026Executive summary
Q1 FY 2026/27 revenue was €533.6m and EBITDA €76.1m; EBIT reached €59.0m and net income €36.0m, versus a €4.0m loss a year earlier.
Higher biofuel prices, stronger biodiesel volumes and margins, and greater GHG quota contributions supported results.
Financial highlights
Revenue rose 21.8% to €533.6m from €438.2m YoY; EBITDA increased to €76.1m from €15.4m, with an EBITDA margin of 14.3% versus 3.5%.
EBIT was €59.0m versus €0.1m; net income was €36.0m versus a €4.0m loss; EPS was €0.56 versus -€0.06.
Operating cash flow was €34.1m versus an outflow of €17.3m; free cash flow was €13.5m versus an outflow of €37.8m.
Q1 EBITDA of €76.1m exceeded Q4’s €69.1m after excluding the prior quarter’s €19.1m positive biomethane valuation effect.
Outlook and guidance
FY 2026/27 EBITDA is expected at the upper end of the €210m–€250m forecast range, reflecting the strong start and better-than-expected market conditions, especially biodiesel spreads.
Improved earnings and lower capital expenditure are expected to drive a further significant YoY reduction in net financial debt; the forecast retains expected business seasonality.
Latest events from Verbio
- From platform expansion to higher-value molecules, chemicals and cash generation.VBK
CMD 2026 presentation - EBITDA surged to EUR 193.9 million, net profit returned, and outlook signals further growth.VBK
Q4 2026 - Record biomethane output and regulatory tailwinds drive EBITDA guidance upward for FY 2025/26.VBK
Q3 2026 - Profitability rebounds as regulatory clarity, innovation, and global expansion drive growth.VBK
German Select VII Conference - Revenue up 19% and EBITDA tripled, driven by higher production and GHG quota demand.VBK
Q2 25/26 - Record biofuel output and growth investments set stage for higher EBITDA in FY 2024/25.VBK
Q4 23/24 - EBITDA and revenue fell, but guidance and regulatory support remain positive for FY 2024/25.VBK
Q1 24/25 - EBITDA and revenue fell, but production hit records; guidance and CapEx were cut.VBK
Q3 24/25 - EBITDA and revenue fell, but Q2 rebounded and guidance was cut amid market and technical headwinds.VBK
Q2 24/25